We investigated the role of the IL-4R–STAT6 signal pathway and its signaling cytokines ... production of both cytokines by T cells from 15-12RM–injected mice after anti-CD3 stimulation ...

Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of ...

INAVO120 trial shows inavolisib, palbociclib, and fulvestrant significantly improved overall survival in PIK3CA-mutant ...

Q1 2025 Earnings Call Transcript May 12, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $-0.31. Operator: Good day and thank you for ...

Discover early autoimmune warning signs doctors miss, from unusual fatigue to distinctive pain patterns and surprising skin changes.

Detailed price information for Aclaris Therapts (ACRS-Q) from The Globe and Mail including charting and trades.

Discussion: These findings characterize ADP-520 as a first-in-class, CD70-targeted, fratricide-resistant autologous TRuC T-cell therapy leveraging native TCR signaling combined with constitutive IL-15 ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...

May 19 - The Atlanta Braves reinstated right-hander Spencer Strider from the 15-day injured list on Monday. The former All-Star went on the IL on April 21 with a strained right hamstring after ...

The Cubs sent Imanaga to the 15-day injured list on Monday, just one day after he left the team's 4-0 loss to the Milwaukee Brewers early due to a hamstring injury. As a result, the Cubs recalled ...